国务院近日印发《知识产权保护和运用“十五五”规划》，将每万人口高价值发明专利拥有量指标设定为大于22件 1。这一目标较“十四五”末的16件水平增长了6件以上 1。为实现这一大幅跃升，规划强调需严把专利入口关、引导资源向重点领域集聚，并进一步强化企业的创新主体地位 1。
在具体措施方面，国家知识产权局已推动1200多所高校和科研机构建立专利申请前评估制度 1。同时，我国发明专利平均审查周期已压减至15个月 1。数据显示，目前28万家企业共拥有高价值发明专利176.4万件，占比77% 1。根据定义，高价值发明专利涵盖属于战略性新兴产业、拥有海外同族、维持时间超过10年或获奖等四种情况 1。市场活跃度也印证了专利价值的提升，2025年全国涉及专利的技术合同成交额达到1.18万亿元，同比增长18.8% 1。典型案例包括中国生物制药与赛诺菲达成的最高总额达15.3亿美元的合作交易 1。
The State Council has issued the "15th Five-Year Plan for Intellectual Property Protection and Utilization," setting a target that the number of high-value invention patents per 10,000 people must exceed 22 1. This benchmark represents an increase of more than six patents compared to the 16 recorded at the end of the previous "14th Five-Year" period, marking a shift from quantity-focused metrics to quality-oriented outcomes 1. The plan, released on October 28, 2026, outlines strategic pathways to achieve this leap, including tightening patent entry standards, directing resources toward key sectors, and reinforcing the role of enterprises as innovation hubs 1.
To support these goals, the National Intellectual Property Administration has facilitated the establishment of pre-application evaluation systems across more than 1,200 universities and research institutions 1. These measures aim to ensure that only robust inventions enter the pipeline, with high-value patents defined by criteria such as belonging to strategic emerging industries, having overseas families, being maintained for over ten years, or winning awards 1. Current data indicates a strong foundation for this growth, as over 70% of China’s high-value invention patents are derived from strategic emerging industries 1. Specifically, 280,000 enterprises hold 1.764 million high-value invention patents, accounting for 77% of the total 1.
Market dynamics reflect this transition toward higher-quality intellectual property assets. In 2025, the transaction volume for technology contracts involving patents reached 1.18 trillion yuan, a year-on-year increase of 18.8% 1. This surge is illustrated by major deals such as the collaboration between China Biopharmaceuticals and Sanofi, which carries a total transaction value of up to $1.53 billion 1. Furthermore, administrative efficiency has improved significantly, with the average examination cycle for invention patents compressed to 15 months 1.
评论
还没有评论，欢迎留下第一条。